Marker Thrptcs Rg
Marker Therapeutics, a Houston‑based clinical‑stage immuno‑oncology company, develops multi‑TAA T cell therapies for AML, myelodysplastic syndromes, lymphoma and pancreatic cancer, targeting non‑engineered tumor‑specific T cells.
Headquarters: United States (USA)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 5
- HQ: Houston
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.